Pfizer revenue rises as pneumonia vaccine sales jump
February 02, 2016 at 06:55 AM EST
(Reuters) - Pfizer Inc , which has agreed to buy Botox-maker Allergan Plc for $160 billion, reported a 7 percent rise in quarterly revenue, helped by its Hospira acquisition and demand for its pneumonia vaccine.
